
    
      The purpose of this study is to compare the difference in medication dosage and total daily
      dose necessary of Astagraf XLÂ® in order to reach therapy goal, when taken with other
      medications that are routinely used for kidney transplantation, which may stop the
      development of a substance that can cause long-term damage to the transplanted kidney.
      African American kidney transplant patients aged 18 and above who are underwent a kidney
      transplant are eligible to participate. The duration of the study is 3 months.
    
  